EMA — authorised 27 August 2018
- Marketing authorisation holder: ALNYLAM NETHERLANDS B.V.
- Status: approved
🇪🇺 Onpattro in European Union
EMA authorised Onpattro on 27 August 2018
Marketing authorisation
Onpattro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Onpattro approved in European Union?
Yes. EMA authorised it on 27 August 2018.
Who is the marketing authorisation holder for Onpattro in European Union?
ALNYLAM NETHERLANDS B.V. holds the EU marketing authorisation.